Literature DB >> 24979724

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients.

Juan A Pineda1, Celia Cifuentes, Manuel Parra, Nicolás Merchante, Elisabet Pérez-Navarro, Antonio Rivero-Juárez, Patricia Monje, Antonio Rivero, Juan Macías, Luis Miguel Real.   

Abstract

OBJECTIVES: To know the prevalence, incidence and factors associated with hepatitis E virus (HEV) infection in HIV-infected individuals in Spain, as well as to provide information on the natural history of HIV/HEV coinfection.
DESIGN: Prospective cohort study.
METHODS: Serum HEV IgG antibodies were tested in 613 HIV-infected patients at baseline and 2 years thereafter. Positive samples were tested for HEV-RNA. In patients with seroconversion, changes in liver function tests, serum HEV IgM antibodies and HEV RNA in samples collected between the baseline and the final time points were analyzed.
RESULTS: One hundred and sixty-one (26%) patients tested positive for serum HEV IgG antibodies at baseline. HEV exposure was more common in men than in women (28 vs. 18%; P = 0.022) and increased linearly with age: 16, 26 and 44% in younger than 40, from 40 to 49 and older than 50 years, respectively (P = 0.000002). One patient bore the serum HEV-RNA at baseline. Eighteen (4%) HEV-seronegative patients seroconverted during the follow-up. None of the factors predicted seroconversion. One patient with seroconversion developed acute hepatitis and four mild hypertransaminasemia without another apparent cause. No case of seroconversion evolved to chronic HEV infection. Seroreversion was detected in 19% of the HEV-seropositive patients at baseline. Patients with seroreversion showed more commonly CD4 cell counts below 500 cells/μl than those who remained seropositive (77 vs. 46%; P = 0.004).
CONCLUSIONS: Exposure to HEV among HIV-infected patients in Spain is very common, and this increases with age. Evolution to chronic infection is extremely unusual. Most cases of acute HEV infection seem to be clinically and biochemically unexpressive, therefore going unnoticed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24979724     DOI: 10.1097/QAD.0000000000000378

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  20 in total

1.  CD8+ lymphocytes but not B lymphocytes are required for protection against chronic hepatitis E virus infection in chickens.

Authors:  Eda Rogers; Stephanie Michelle Todd; Frank William Pierson; Scott P Kenney; Connie Lynn Heffron; Danielle M Yugo; Shannon R Matzinger; Elena Mircoff; Irene Ngo; Charles Kirby; Michaela Jones; Paul Siegel; Peter Jobst; Karen Hall; Robert J Etches; Xiang-Jin Meng; Tanya LeRoith
Journal:  J Med Virol       Date:  2019-07-25       Impact factor: 2.327

2.  Hepatitis E virus infection prevalence among men who have sex with men involved in a hepatitis A virus outbreak in Italy.

Authors:  Enea Spada; Angela Costantino; Patrizio Pezzotti; Roberto Bruni; Giulio Pisani; Elisabetta Madonna; Paola Chionne; Matteo Simeoni; Umbertina Villano; Cinzia Marcantonio; Stefania Taffon; Giuseppe Marano; Simonetta Pupella; Giancarlo M Liumbruno; Anna R Ciccaglione
Journal:  Blood Transfus       Date:  2019-11       Impact factor: 3.443

3.  Hepatitis E in a Portuguese cohort of human immunodeficiency virus positive patients: High seroprevalence but no chronic infections.

Authors:  Rita Filipe; Beatriz Prista-Leão; André Silva-Pinto; Isabel Abreu; Rosário Serrão; Rosário Costa; Edite Guedes; Joana Sobrinho-Simões; António Sarmento; Carmo Koch; Lurdes Santos
Journal:  Health Sci Rep       Date:  2022-05-20

4.  Hepatitis E virus detection in hunted wild boar (Sus scrofa) livers in Central Italy.

Authors:  Gianluigi Ferri; Andrea Piccinini; Alberto Olivastri; Alberto Vergara
Journal:  Ital J Food Saf       Date:  2022-06-21

Review 5.  Hepatitis E Virus in the Food of Animal Origin: A Review.

Authors:  Gianluigi Ferri; Alberto Vergara
Journal:  Foodborne Pathog Dis       Date:  2021-03-30       Impact factor: 3.171

6.  Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran.

Authors:  Hassan Joulaei; Omid Rudgari; Nasrin Motazedian; Samaneh Gorji-Makhsous
Journal:  Iran J Microbiol       Date:  2015-04

Review 7.  Hepatitis E Virus in Industrialized Countries: The Silent Threat.

Authors:  Pilar Clemente-Casares; Carlota Ramos-Romero; Eugenio Ramirez-Gonzalez; Antonio Mas
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

8.  Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women.

Authors:  Mark H Kuniholm; Edgar Ong; Boris M Hogema; Marco Koppelman; Kathryn Anastos; Marion G Peters; Eric C Seaberg; Yue Chen; Kenrad E Nelson; Jeffrey M Linnen
Journal:  Hepatology       Date:  2016-01-16       Impact factor: 17.425

9.  Hepatitis E virus (HEV): seroprevalence and HEV RNA detection in subjects attending a sexually transmitted infection clinic in Brussels, Belgium.

Authors:  N Dauby; V Suin; M Jacques; M Abady; S VAN DEN Wijngaert; M Delforge; S DE Wit; A Libois
Journal:  Epidemiol Infect       Date:  2017-11-06       Impact factor: 4.434

10.  Increased Hepatitis E Virus Seroprevalence Correlates with Lower CD4+ Cell Counts in HIV-Infected Persons in Argentina.

Authors:  José D Debes; Maribel Martínez Wassaf; María Belén Pisano; María Beatriz Isa; Martin Lotto; Leonardo G Marianelli; Natalia Frassone; Estefania Ballari; Paul R Bohjanen; Bettina E Hansen; Viviana Ré
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.